Reply to Bazaz and Denning

Affiliations

¹ University of Crete, and Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, Heraklion, Crete, Greece.
² Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
³ Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, Texas.

Comment

Georgios Chamilos et al. Clin Infect Dis. 2018.

. 2018 Jun 18;67(1):157-159.

doi: 10.1093/cid/ciy039.

¹ University of Crete, and Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, Heraklion, Crete, Greece.
² Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
³ Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, Texas.

No abstract available

Comment on

Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.
Chamilos G, Lionakis MS, Kontoyiannis DP. Chamilos G, et al. Clin Infect Dis. 2018 Jan 6;66(1):140-148. doi: 10.1093/cid/cix687. Clin Infect Dis. 2018. PMID: 29029010 Free PMC article.
Subacute Invasive Aspergillosis Associated With Sorafenib Therapy for Hepatocellular Carcinoma.
Bazaz R, Denning DW. Bazaz R, et al. Clin Infect Dis. 2018 Jun 18;67(1):156-157. doi: 10.1093/cid/ciy038. Clin Infect Dis. 2018. PMID: 29370392 No abstract available.

1. Bazaz R, Denning DW. Subacute invasive aspergillosis associated with sorafenib therapy for hepatocellular carcinoma. Clin Infect Dis 2018; 67: 156–7. - PubMed
1. Chamilos G, Lionakis MS, Kontoyiannis DP. Call for action: invasive fungal infections associated with ibrutinib and other small molecule kinase inhibitors targeting immune signaling pathways. Clin Infect Dis 2018;66: 140–8. - PMC - PubMed
1. Kloos RT, Ringel MD, Knopp MV et al. Phase II trial of sorafenib in metastatic thyroid cancer. J Clin Oncol 2009; 27:1675–84. - PMC - PubMed
1. Locati LD, Perrone F, Cortelazzi B et al. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: translational analyses and clinical impact. Eur J Cancer 2016; 69:158–65. - PubMed
1. Chan JF, Chan TS, Gill H et al. Disseminated infections with Talaromyces marneffei in non-AIDS patients given monoclonal antibodies against CD20 and kinase inhibitors. Emerg Infect Dis 2015; 21:1101–6. - PMC - PubMed